Microbial-host isozyme: A novel target in "drug the bug" strategies for diabetes
- PMID: 37793343
- DOI: 10.1016/j.cmet.2023.09.008
Microbial-host isozyme: A novel target in "drug the bug" strategies for diabetes
Abstract
The role of the gut microbiome in metabolic diseases, such as diabetes, has emerged as a pivotal area of medical research. Wang et al.'s recent work reported that a gut bacteria-derived microbial-host isozyme, mimicking a human enzyme responsible for blood glucose regulation, can significantly impact the efficacy of diabetes medications.
Copyright © 2023. Published by Elsevier Inc.
Conflict of interest statement
Declaration of interests L.Z. is a co-founder of Notitia Biotechnologies Company.
Comment on
-
Microbial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic target.Science. 2023 Aug 4;381(6657):eadd5787. doi: 10.1126/science.add5787. Epub 2023 Aug 4. Science. 2023. PMID: 37535747
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
